Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) current consensus investment analysts is to Buy http://theindependentrepublic.com/2017/01/12/immune-pharmaceuticals-inc-nasdaqimnp-current-consensus-investment-analysts-is-to-buy-3/ Investor 100